FDA Experts Give Green Light To New, Non-mRNA Novavax COVID-19 Vaccine …

Novavax presented data to the committee showing that its vaccine was 90% effective in preventing mild and severe COVID-19 cases with a strong safety profile. However, some committee members expressed concern that the trials on the vaccine were conducted during the Alpha and Delta waves of the pandemic, and that some efficacy may be lost against …

https://dailycaller.com/2022/06/07/fda-authorization-covid-coronavirus-vaccine-novavax-mrna/